Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP657220.RAFs2dlYI1vW3DBWFkvqFRxZck-9-x4k-a8UUCn8dUUJc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP657220.RAFs2dlYI1vW3DBWFkvqFRxZck-9-x4k-a8UUCn8dUUJc130_assertion type Assertion NP657220.RAFs2dlYI1vW3DBWFkvqFRxZck-9-x4k-a8UUCn8dUUJc130_head.
- NP657220.RAFs2dlYI1vW3DBWFkvqFRxZck-9-x4k-a8UUCn8dUUJc130_assertion wasGeneratedBy ECO_0000203 NP657220.RAFs2dlYI1vW3DBWFkvqFRxZck-9-x4k-a8UUCn8dUUJc130_provenance.
- NP657220.RAFs2dlYI1vW3DBWFkvqFRxZck-9-x4k-a8UUCn8dUUJc130_assertion wasDerivedFrom befree-20140225 NP657220.RAFs2dlYI1vW3DBWFkvqFRxZck-9-x4k-a8UUCn8dUUJc130_provenance.
- NP657220.RAFs2dlYI1vW3DBWFkvqFRxZck-9-x4k-a8UUCn8dUUJc130_assertion SIO_000772 17962208 NP657220.RAFs2dlYI1vW3DBWFkvqFRxZck-9-x4k-a8UUCn8dUUJc130_provenance.
- NP657220.RAFs2dlYI1vW3DBWFkvqFRxZck-9-x4k-a8UUCn8dUUJc130_assertion evidence source_evidence_literature NP657220.RAFs2dlYI1vW3DBWFkvqFRxZck-9-x4k-a8UUCn8dUUJc130_provenance.
- NP657220.RAFs2dlYI1vW3DBWFkvqFRxZck-9-x4k-a8UUCn8dUUJc130_assertion description "[Our study demonstrates that (i) ErbB/HER ligands, including BTC and EREG, are expressed in most breast cancers; and (ii) TGFalpha, HB-EGF and NRG2 high expressions are related to the biological aggressiveness of the tumours.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP657220.RAFs2dlYI1vW3DBWFkvqFRxZck-9-x4k-a8UUCn8dUUJc130_provenance.